Bio-TechneMEX:TECH 83 Dividend Payout Ratio is 0.15 as of Mar. 2026, which is 38% below its 10-year median of 0.24. GuruFocus rates MEX:TECH with a GF Score™ of 83/100 and a GF Value™ of MXN1,112.56. The stock has 8 warning signs investors should review. Among 134 Biotechnology companies, Bio-Techne ranks better than 82.84% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Bio-Techne's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.15.
The historical rank and industry rank for Bio-Techne's Dividend Payout Ratio or its related term are showing as below:
MEX:TECH'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.12 Med: 0.24 Max: 0.36
Current: 0.12
During the past 13 years, the highest Dividend Payout Ratio of Bio-Techne was 0.36. The lowest was 0.12. And the median was 0.24.
MEX:TECH's Dividend Payout Ratio is ranked better than 82.84% of 134
companies
in the Biotechnology industry
Industry Median: 0.445
vs MEX:TECH: 0.12
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bio-Techne was 13.90% per year. The lowest was 0.00% per year. And the median was 0.10% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Bio-Techne (MEX:TECH) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Bio-Techne Dividend Payout Ratio Related Terms
Bio-Techne Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Bio-Techne's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TECH vs HALO, IBRX, NUVL: Dividend Payout Ratio Comparison
For the Biotechnology subindustry, Bio-Techne's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne Dividend Payout Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Techne's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Bio-Techne's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Bio-Techne's Dividend Payout Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne (MEX:TECH) has a Dividend Payout Ratio of 0.15 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Bio-Techne and its competitors. This is 38% below median its historical median of 0.24. Over the past decade, Bio-Techne's Dividend Payout Ratio has ranged from 0.12 to 0.36. According to the industry distribution chart, Bio-Techne ranks #23 out of 134 companies in the Biotechnology industry, placing it in the top 17.2%.
Is Bio-Techne's Dividend Payout Ratio too high?
Bio-Techne's current Dividend Payout Ratio of 0.15 is 38% below median its 10-year median of 0.24. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 0.36. The Biotechnology industry median Dividend Payout Ratio is 0.45. Bio-Techne's value of 0.15 is 66.3% below this industry median. Based on the distribution chart, Bio-Techne ranks #23 out of 134 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bio-Techne has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Dividend Payout Ratio compare to HALO and IBRX?
According to the Biotechnology industry distribution chart, Bio-Techne ranks #23 out of 134 companies for Dividend Payout Ratio. This places Bio-Techne in the top 17% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.45. Bio-Techne's value of 0.15 is 66.3% below this benchmark. Historically, Bio-Techne's own Dividend Payout Ratio has ranged from 0.12 to 0.36 over the past decade. While the company's 10-year median is 0.24 vs. the industry median of 0.45, Bio-Techne has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.45, based on 134 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio-Techne's current Dividend Payout Ratio of 0.15 is 66.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Bio-Techne and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Techne's current Dividend Payout Ratio is 0.15, which is 38% below median its own 10-year median of 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current Dividend Payout Ratio of 0.15. The stock's GF Value™ is MXN1,112.56, compared to a current price of MXN1,090.00 — trading 2% below its estimated fair value. The current Dividend Payout Ratio is 0.15, which is 38% below median its 10-year median of 0.24 and 66.3% below the Biotechnology industry median of 0.45. Bio-Techne's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current Dividend Payout Ratio is 0.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Techne (MEX:TECH) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued.
The current stock price of MXN1,090.00 is trading 2% below its estimated GF Value™ of MXN1,112.56.
Key valuation signals for MEX:TECH:
Dividend Payout Ratio: 0.15 (38% below median its 10-year median of 0.24)
GF Value™: MXN1,112.56 vs. price of MXN1,090.00 (2% below fair value)
Industry Position: 66.3% below the Biotechnology median (#23 of 134)
No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
83GF Score
Get the complete analysis for MEX:TECH
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TECH has been successfully added to your 
